Workup for MRSA Urinary Tract Infection
For suspected MRSA urinary tract infection, obtain blood cultures in addition to urine culture with antimicrobial susceptibility testing, particularly in patients without typical UTI symptoms, those with indwelling catheters, or those with structural urinary tract abnormalities.
Initial Diagnostic Approach
The workup for MRSA UTI differs significantly from typical UTI evaluation because S. aureus bacteriuria—especially MRSA—carries substantial risk for invasive disease and mortality that demands aggressive investigation.
Essential Laboratory Studies
- Urine culture with colony count and susceptibility testing: Required to confirm MRSA and guide therapy 1
- Blood cultures: Critical in the following scenarios:
The rationale for blood cultures is compelling: 22.3% of MRSA bacteriuria cases develop invasive S. aureus disease within 12 months, compared to only 8.4% of MSSA cases 1. Patients without UTI symptoms are paradoxically at higher risk for invasive disease and death 1.
Risk Stratification
Identify high-risk features that increase likelihood of complicated infection:
Patient factors:
- Male sex (more common) 2
- High Charlson comorbidity scores 2
- Dependence for daily activities 2
- Diabetes mellitus 4
- Hypoalbuminemia (particularly for MRSA) 3
Urologic factors requiring imaging:
- Indwelling catheterization or recent urinary manipulation 2, 3
- Renal stones 3
- Hydronephrosis 3
- History of urologic procedures (e.g., TURP) 4
Imaging Studies
Obtain renal ultrasound or CT urography to evaluate for:
- Hydronephrosis (odds ratio 7.0 for symptomatic UTI) 3
- Renal stones (odds ratio 1.2 for symptomatic UTI) 3
- Perinephric abscess
- Structural abnormalities
These structural abnormalities are independent risk factors for progression from bacteriuria to symptomatic UTI 3.
Additional Monitoring
- Serial blood cultures if initial cultures positive, to document clearance
- Echocardiography if bacteremia persists >2-3 days or clinical findings suggest endocarditis, as MRSA bacteremia can seed cardiac valves 5
- Repeat urine culture after 48-72 hours of appropriate therapy to confirm microbiologic response
Critical Clinical Pitfalls
Do not dismiss asymptomatic MRSA bacteriuria: The absence of typical UTI symptoms actually predicts worse outcomes (odds ratio 3.21 for invasive disease) 1. This counterintuitive finding suggests MRSA bacteriuria without pyuria may represent hematogenous seeding of the urinary tract rather than ascending infection.
Do not assume low pathogenicity: While S. aureus is traditionally considered a low-virulence uropathogen, MRSA UTI can progress to sepsis, bacteremia, and even meningitis 4. The 30-day mortality for MRSA bacteriuria reaches 23.6% in some cohorts 1.
Persistent bacteremia (odds ratio 7.88 for mortality) mandates investigation for metastatic foci including endocarditis, vertebral osteomyelitis, and epidural abscess 2.
Antimicrobial Susceptibility Considerations
While the IDSA MRSA guidelines 5 focus primarily on skin/soft tissue, pneumonia, and bacteremia rather than UTI specifically, understanding resistance patterns guides empiric therapy:
- Expect 100% resistance to beta-lactams (flucloxacillin, co-amoxiclav) 6
- Ciprofloxacin resistance approaches 98% 6
- Nitrofurantoin resistance varies (2.7-53.7% depending on geographic region) 6, 7
- Vancomycin and teicoplanin maintain 100% susceptibility 6
The high MRSA prevalence (40.9% of S. aureus UTI cases) means empiric coverage is often inadequate, with 59.7% of MRSA cases receiving inappropriate initial therapy 2.